Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Rhinology ; 51(3): 265-7, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23943735

RESUMEN

BACKGROUND: The aim of this study is to investigate nasal and paranasal signs and symptoms of the primary Sjogren`s syndrome patients and compare them with healthy controls. METHODOLOGY: Seventy-seven (7 M, 70 F) primary Sjogren`s syndrome patients and 77 healthy controls were included in the study. Anterior rhinoscopy, nasal endoscopy, 5 component smell discrimination test, nasal clearance analysis with saccharin test and electrorhinomanometer were performed. RESULTS: Nasal crusting was present in 31 and 24 individuals in patient and control groups, respectively. Sinusitis was present in 2 and 1 individuals in patient and control groups, respectively. Nasal polyposis was present in 7 and 1 individuals in patient and control groups, respectively. These differences were not statistically different. CONCLUSION: Although there were some findings in a few patients, nasal findings were insignificant and mild even in patients with severe oral or ocular findings. Rhinomanometry, nasal clearance determination or smell discrimination tests have very little value in the diagnosis or management of primary Sjogren`s syndrome. Nasal polyposis was higher in the patient group, though it did not reach a significant level. Nasal glandular involvement is mild and insignificant in primary Sjogren`s syndrome.


Asunto(s)
Enfermedades Nasales/etiología , Enfermedades de los Senos Paranasales/etiología , Síndrome de Sjögren/complicaciones , Adulto , Anciano , Estudios de Casos y Controles , Distribución de Chi-Cuadrado , Endoscopía , Femenino , Humanos , Masculino , Persona de Mediana Edad , Rinomanometría , Olfato
2.
Acta Neurol Scand ; 118(3): 189-92, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18355394

RESUMEN

OBJECTIVES: To determine the prevalence of headache in patients with primary Sjögren's syndrome (pSS) and to examine the relationship between headache types and clinical, serologic features of the disease. METHODS: The study enclosed 133 patients with the diagnoses of pSS and 97 healthy controls. A questionnaire designed to assess the presence of headache and if present to classify it according to the criteria of the International Headache Society was used. RESULTS: In 133 of the pSS patients evaluated, 104 had headache. No association was present between types of headache and the clinical and laboratory manifestations of the disease. Both migraine and tension-type headache were more common in patients with pSS when compared with healthy controls (P < 0.001). CONCLUSIONS: The high prevalence of migraine in pSS patients might be explained by a vascular headache triggered by immuno-mediated disease activity without an obvious clinic or laboratory marker.


Asunto(s)
Cefalea/epidemiología , Cefalea/etiología , Síndrome de Sjögren/complicaciones , Estudios Transversales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Prevalencia , Encuestas y Cuestionarios
3.
Scand J Rheumatol ; 35(5): 379-83, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17062438

RESUMEN

OBJECTIVES: The aim of this study was to determine the prevalence of primary Sjögren's syndrome (pSS) according to European criteria (1993) and to the US-European Consensus Group (US-EU) criteria (2002) in adult women in Bornova, Izmir, Turkey. MATERIALS AND METHOD: The study was designed as a two-phase cross-sectional survey consisting of a baseline questionnaire and collection of blood samples and clinical examination. In the initial phase, positivity for autoantibodies Ro(SS-A), La(SS-B), rheumatoid factor (RF), and anti-nuclear antibodies (ANA) was determined, and in the clinical phase, clinical examination, salivary and ocular tests were performed. Minor salivary gland biopsy was performed for those who had at least three of these five criteria positive. RESULTS: In our sample the prevalence of SS was 1.56% [95% confidence interval (CI) 0.92-2.66] according to the European criteria and 0.72% (95% CI 0.33-1.57) according to the US-EU criteria. CONCLUSION: To prevent the loss in diagnosis of pSS, the addition of ANA, RF, and tear break-up time (BUT) tests to US-EU criteria would be appropriate.


Asunto(s)
Guías como Asunto , Síndrome de Sjögren/diagnóstico , Síndrome de Sjögren/epidemiología , Adolescente , Adulto , Anciano , Autoantígenos/sangre , Estudios Transversales , Diagnóstico Diferencial , Europa (Continente) , Femenino , Humanos , Persona de Mediana Edad , Prevalencia , Factor Reumatoide/sangre , Ribonucleoproteínas/sangre , Síndrome de Sjögren/inmunología , Encuestas y Cuestionarios , Turquía/epidemiología , Estados Unidos , Antígeno SS-B
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda